Protein kinase Cζ represses the interleukin-6 promoter and impairs tumorigenesis in vivo▼

Molecular and Cellular Biology

Volumn 29, Issue 1, 2009, Pages 104-115

  Galvez, Anita S ^a   Duran, Angeles ^a   Linares, Juan F ^a   Pathrose, Peterson ^a   Castilla, Elias A ^a   Abu Baker, Shadi ^a   Leitges, Michael ^b   Diaz Meco, Maria T ^a   Moscat, Jorge ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CASPASE 3; CCAAT ENHANCER BINDING PROTEIN BETA; CD31 ANTIGEN; CYCLIN D1; HISTONE; INTERLEUKIN 6; MESSENGER RNA; PROTEIN KINASE C ZETA; PROTEIN P62; RAS PROTEIN; STAT3 PROTEIN; VASCULOTROPIN RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; FEMALE; GENE REPRESSION; IN VIVO STUDY; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR XENOGRAFT; ANIMAL; CELL LINE; CELL PROLIFERATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; ONCOGENE RAS; PATHOLOGY; SERUM;

MUS;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; INTERLEUKIN-6; LUNG NEOPLASMS; MICE; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN KINASE C; SERUM; TRANSCRIPTION, GENETIC;

EID: 58149473474     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01294-08     Document Type: Article

References (35)

1. Amsen, D., J. M. Blander, G. R. Lee, K. Tanigaki, T. Honjo, and R. A. Flavell. 2004. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117:515-526.
2. Ancrile, B., K. H. Lim, and C. M. Counter. 2007. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev. 21:1714-1719.
3. Balkwill, F., K. A. Charles, and A. Mantovani. 2005. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211-217.
4. Barradas, M., A. Monjas, M. T. Diaz-Meco, M. Serrano, and J. Moscat. 1999. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. EMBO J. 18:6362-6369.
5. Berra, E., M. T. Diaz-Meco, I. Dominguez, M. M. Municio, L. Sanz, J. Lozano, R. S. Chapkin, and J. Moscat. 1993. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74:555-563.
6. Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
7. Diaz-Meco, M. T., J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz, and J. Moscat. 1994. Evidence for the in vitro and in vivo interaction of Ras with protein kinase C zeta. J. Biol. Chem. 269:31706-31710.
8. Duran, A., M. T. Diaz-Meco, and J. Moscat. 2003. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J. 22:3910-3918.
9. Duran, A., J. F. Linares, A. S. Galvez, K. Wikenheiser, J. M. Flores, M. T. Diaz-Meco, and J. Moscat. 2008. The signaling adaptor p62 is an important NF-[kappa]B mediator in tumorigenesis. Cancer Cell 13:343-354.
10. Duran, A., M. Serrano, M. Leitges, J. M. Flores, S. Picard, J. P. Brown, J. Moscat, and M. T. Diaz-Meco. 2004. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev. Cell 6:303-309.
11. Fisher, G. H., S. L. Wellen, D. Klimstra, J. M. Lenczowski, J. W. Tichelaar, M. J. Lizak, J. A. Whitsett, A. Koretsky, and H. E. Varmus. 2001. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev. 15:3249-3262.
12. Gao, T., A. Toker, and A. C. Newton. 2001. The carboxyl terminus of protein kinase C provides a switch to regulate its interaction with the phosphoinosi-tide-dependent kinase, PDK-1. J. Biol. Chem. 276:19588- 19596.
13. Garcia-Cao, I., M. Lafuente, L. Criado, M. Diaz-Meco, M. Serrano, and J. Moscat. 2003. Genetic inactivation of Par4 results in hyperactivation of NF-kB and impairment of JNK and p38. EMBO Rep. 4:307-312.
14. Grivennikov, S., and M. Karin. 2008. Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13:7-9.
15. Guerra, C., N. Mijimolle, A. Dhawahir, P. Dubus, M. Barradas, M. Serrano, V. Campuzano, and M. Barbacid. 2003. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4:111-120.
16. Hagemann, T., T. Lawrence, I. McNeish, K. A. Charles, H. Kulbe, R. G. Thompson, S. C. Robinson, and F. R. Balkwill. 2008. "Re-educating" tumor-associated macrophages by targeting NF-kB. J. Exp. Med. 205:1261-1268.
17. Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57-70.
18. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132:344-362.
19. Inoue, T., T. Yoshida, Y. Shimizu, T. Kobayashi, T. Yamasaki, Y. Toda, T. Segawa, T. Kamoto, E. Nakamura, and O. Ogawa. 2006. Requirement of androgen-dependent activation of protein kinase Czeta for androgen-depen-dent cell proliferation in LNCaP Cells and its roles in transition to androgen-independent cells. Mol. Endocrinol. 20:3053-3069.
20. Kuilman, T., C. Michaloglou, L. C. Vredeveld, S. Douma, R. van Doorn, C. J. Desmet, L. A. Aarden, W. J. Mooi, and D. S. Peeper. 2008. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019-1031.
21. Leitges, M., L. Sanz, P. Martin, A. Duran, U. Braun, J. F. Garcia, F. Camacho, M. T. Diaz-Meco, P. D. Rennert, and J. Moscat. 2001. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. Mol. Cell 8:771-780.
22. Malkinson, A. M. 1991. Promoters, co-carcinogens and inhibitors of pulmonary carcinogenesis in mice: an overview. Exp. Lung Res. 17:435-437.
23. Mayo, M. W., C. Y. Wang, P. C. Cogswell, K. S. Rogers-Graham, S. W. Lowe, C. J. Der, and A. S. Baldwin, Jr. 1997. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812-1815.
24. Meuwissen, R., and A. Berns. 2005. Mouse models for human lung cancer. Genes Dev. 19:643-664.
25. Moscat, J., M. T. Diaz-Meco, A. Albert, and S. Campuzano. 2006. Cell signaling and function organized by PB1 domain interactions. Mol. Cell 23:631-640.
26. Moscat, J., M. T. Diaz-Meco, and M. W. Wooten. 2007. Signal integration and diversification through the p62 scaffold protein. Trends Biochem. Sci. 32:95-100.
27. Moscat, J., P. Rennert, and M. T. Diaz-Meco. 2006. PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ. 13:702-711.
28. Naugler, W. E., T. Sakurai, S. Kim, S. Maeda, K. Kim, A. M. Elsharkawy, and M. Karin. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121-124.
29. Pollard, J. W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4:71-78.
30. Rhodes, D. R., S. Kalyana-Sundaram, V. Mahavisno, R. Varambally, J. Yu, B. B. Briggs, T. R. Barrette, M. J. Anstet, C. Kincead-Beal, P. Kulkarni, S. Varambally, D. Ghosh, and A. M. Chinnaiyan. 2007. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166-180.
31. Sansone, P., G. Storci, S. Tavolari, T. Guarnieri, C. Giovannini, M. Taf-furelli, C. Ceccarelli, D. Santini, P. Paterini, K. B. Marcu, P. Chieco, and M. Bonafe. 2007. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Investig. 117:3988-4002.
32. Sanz, L., M. T. Diaz-Meco, H. Nakano, and J. Moscat. 2000. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the TRAF6 pathway. EMBO J. 19:1576-1586.
33. Tuveson, D. A., A. T. Shaw, N. A. Willis, D. P. Silver, E. L. Jackson, S. Chang, K. L. Mercer, R. Grochow, H. Hock, D. Crowley, S. R. Hingorani, T. Zaks, C. King, M. A. Jacobetz, L. Wang, R. T. Bronson, S. H. Orkin, R. A. DePinho, and T. Jacks. 2004. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5:375-387.
34. Wood, L. D., D. W. Parsons, S. Jones, J. Lin, T. Sjoblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J. K. V. Willson, S. Sukumar, K. Polyak, B. H. Park, C. L. Pethiyagoda, P. V. K. Pant, D. G. Ballinger, A. B. Sparks, J. Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S. D. Markowitz, G. Parmigiani, K. W. Kinzler, V. E. Velculescu, and B. Vogelstein. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.
35. Wooten, M. W., T. Geetha, M. L. Seibenhener, J. R. Babu, M. T. Diaz-Meco, and J. Moscat. 2005. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J. Biol. Chem. 280:35625-35629.